Taking Ownership of the Early Morning Routine for children with ADHD

At Highland Therapeutics we strive to create meaningful improvements in everyday life with innovations that go beyond simple convenience.

> Latest News

> Contact Us


Press Releases


What We Do

Our Approach

Our Approach

The benefits of our lead products are targeted at helping ADHD patients and their families improve the quality of their lives by leveraging proprietary technologies to address a significant unmet medical need – the lack of control of symptoms of ADHD during the morning routine.

Early Morning Functioning

Early Morning Functioning

A majority of surveyed families report ADHD symptoms as ‘severe’ or ‘moderate-to-severe’ during the morning routine – the period immediately upon waking until the patient leaves for work or school. This period is often the busiest and most chaotic for families.

Controlled Release

Controlled Release

Highland Therapeutics, through its wholly owned subsidiary Ironshore Pharmaceuticals & Development, Inc., has developed a proprietary, oral controlled-release technology that enables evening dosing of medication with delayed and extended release characteristics that provide for next-day therapeutic activity beginning in the early morning and lasting throughout the day.


Community Support

MaRS Building

Highland Therapeutics Inc. is a client of MaRS Discovery District’s Health Venture Services group, which provides advisory services, connections to talent, customer & capital networks, and market intelligence to high-impact, Ontario-based life sciences ventures, helping them commercialize their ideas and build globally competitive companies.



Highland Therapeutics Inc.

MaRS Centre
South Tower, Suite 310
101 College St.
Toronto, ON, Canada
M5G 1L7

T. 1.647.260.7875

Follow us on LinkedIn:

Email (all fields required)